UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 88 filers reported holding UNITY BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $43,000 | – | 8,206 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund V Management, LLC | 491,751 | $275,000 | 2.22% |
| GSA CAPITAL PARTNERS LLP | 639,937 | $361,000 | 0.05% |
| PURA VIDA INVESTMENTS, LLC | 359,089 | $202,000 | 0.01% |
| Caption Management, LLC | 725,000 | $409,000 | 0.01% |
| Forefront Analytics, LLC | 20,377 | $11,000 | 0.01% |
| Johnson Midwest Financial, LLC | 6,100 | $3,000 | 0.00% |
| Virtu Financial LLC | 62,640 | $35,000 | 0.00% |
| Caption Management, LLC | 225,000 | $127,000 | 0.00% |
| SeaCrest Wealth Management, LLC | 25,000 | $14,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 191,450 | $108,000 | 0.00% |